Cas:2388-10-5 Lithium isopropoxide manufacturer & supplier

Chemical Name:Lithium isopropoxide

CAS.NO:2388-10-5

Synonyms:2-Propanol, lithium salt (1:1);lithium i-propoxide;MFCD00048286;Lithium isopropoxide solution;Lithium 2-propanolate;Lithium Iso Propoxide;Lithiumisopropylat;Lithium isopropoxide

Molecular Formula:C₃H₇LiO

Molecular Weight:66.028

HS Code:2915900090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:68-72 °C

Density:0.897 g/mL at 25 °C

Index of Refraction:

PSA:23.06000

Exact Mass:66.065697

LogP:0.82530

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:UN 3206 4.2/PG 2

Packing Group:III

Contact us for information like 2-Propanol, lithium salt (1:1) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Lithium isopropoxide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,lithium i-propoxide Use and application,2-Propanol, lithium salt (1:1) technical grade,usp/ep/jp grade.

Related News: The GLOW trial doesn’t yet have the answer to that question, but Tendler pointed to encouraging early evidence from the regimen’s phase 2 trial, dubbed CAPTIVATE. Among eight patients who progressed after stopping the fixed-duration combo, six responded to subsequent Imbruvica monotherapy, while the other two didn’t have a response report, according to data presented at the recent American Society of Clinical Oncology annual meeting. Lithium isopropoxide manufacturer f you’ve traveled in or transited through mainland China, you won’t be allowed into New Zealand unless you’re a New Zealand national. Lithium isopropoxide supplier Pre-approval Access Programs (also known as expanded access, early access, compassionate use, named patient supply) are regulatory-compliant processes permitting experimental agents in development to be made available upon the request of a physician or a patient for appropriate patients for whom no alternative treatment option exists in their country. Lithium isopropoxide vendor Pre-approval Access Programs (also known as expanded access, early access, compassionate use, named patient supply) are regulatory-compliant processes permitting experimental agents in development to be made available upon the request of a physician or a patient for appropriate patients for whom no alternative treatment option exists in their country. Lithium isopropoxide factory The Philippines, the United States and Australia have expanded travel restrictions, temporarily barring noncitizens who have recently traveled to China.